Drug Trial Radar · NCT06915766
Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis
Last checked: Nov 20, 2026Latest source record: Jul 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Available
Enrollment
Not stated
Start
Not stated
Primary completion
Not stated
Sponsor
- Lead sponsor
- Cogent Biosciences, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 8, 2025
Design
- Study type
- Expanded access
- Who can join
- All sexes, from 18 years
Summary
As written by the sponsor on the registry.
The purpose of this expanded access program (EAP) protocol is to provide investigational bezuclastinib to patients with a diagnosis of nonadvanced systemic mastocytosis (NonAdvSM) or advanced systemic mastocytosis (AdvSM) who have received and failed or been intolerant to at least one standard approved therapy and/or have no comparable or satisfactory alternative therapy options.
Conditions
- Systemic Mastocytoses, Indolent
- Systemic Mastocytoses, Aggressive
Interventions
BezuclastinibDrug
Drug: Bezuclastinib Tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
23 sites in 1 country. Site status is shown where the registry gives one.
Orso Health/Modena Asthma Allergy
La Jolla, California · Available
Scripps Green Hospital
La Jolla, California · Available
UCLA Ronald Reagan Medical Center
Los Angeles, California · Available
Sneeze Wheeze & Itch Associates LLC Clinical Research Center
Normal, Illinois · Available
Indiana University Health
Indianapolis, Indiana · Available
Northern Light Eastern Maine Medical Center
Bangor, Maine · Available
Walter Reed
Bethesda, Maryland · Available
AllerVie Health
Glenn Dale, Maryland · Available
Boston Specialists
Boston, Massachusetts · Available
Dana Farber Cancer Institute
Boston, Massachusetts · Available
Michigan Medicine- University of Michigan
Ann Arbor, Michigan · Available
Mayo Clinic
Rochester, Minnesota · Available
Washington University School of Medicine in St. Louis
St Louis, Missouri · Available
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire · Available
Memorial Sloan Kettering Cancer Center
New York, New York · Available
Duke Blood Cancer Center
Durham, North Carolina · Available
The Ohio State University Wexner Medical Center
Columbus, Ohio · Available
AIR Care
Dallas, Texas · Available
Texas Children's Hospital
Houston, Texas · Available
The University of Texas, MD Anderson Cancer Center
Houston, Texas · Available
University of Utah - Huntsman Cancer Institute
Salt Lake City, Utah · Available
Allergy Associates of Utah
Sandy City, Utah · Available
Northwest Medical Specialties
Tacoma, Washington · Available
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.